These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3530205)

  • 1. [Role of modern methods of morphological research in the exact definition of the biological characteristics and morphogenesis of human breast cancer].
    Dorosevich AE; Naperstnikov VV; Bazhenov SM
    Arkh Patol; 1986; 48(7):3-9. PubMed ID: 3530205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Breast fibroadenoma: the morphological characteristics, morphogenesis and prognosis].
    Dorosevich AE; Golubev OA
    Arkh Patol; 1991; 53(5):74-7. PubMed ID: 1883288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Carcinoma with carcinoid differentiation. Differential diagnostic interpretation of an unusual malignant breast tumor].
    Prechtel K; Wurster K; Dittmar FW; Schierwarter B; Schünemann W
    Pathologe; 1993 Jan; 14(1):25-9. PubMed ID: 8451223
    [No Abstract]   [Full Text] [Related]  

  • 4. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion.
    Platet N; Cathiard AM; Gleizes M; Garcia M
    Crit Rev Oncol Hematol; 2004 Jul; 51(1):55-67. PubMed ID: 15207254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ultrastructural characteristics of the parenchymatous and stromal components and their interrelationship in breast cancer].
    Naperstnikov VV; Dorosevich AE
    Arkh Patol; 1985; 47(4):65-70. PubMed ID: 3159377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
    Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma.
    Acs G; Dumoff KL; Solin LJ; Pasha T; Xu X; Zhang PJ
    Am J Surg Pathol; 2007 Jan; 31(1):129-40. PubMed ID: 17197929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential atypical ductal hyperplasia/DCIS/invasive carcinoma diagnosis and significance of micrometastases].
    Stosiek P
    Zentralbl Chir; 1998; 123 Suppl 5():13. PubMed ID: 10063563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving a biological profile of the breast cancer patient.
    Baum M
    Experientia Suppl; 1982; 41():69-85. PubMed ID: 6958541
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant phyllodes tumour with intraductal and invasive carcinoma and lymph node metastasis.
    Korula A; Varghese J; Thomas M; Vyas F; Korula A
    Singapore Med J; 2008 Nov; 49(11):e318-21. PubMed ID: 19037540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of prognostic factors in breast cancer].
    Durand M
    Bull Cancer; 1984; 71(4):331-5. PubMed ID: 6498347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer.
    Woo SU; Bae JW; Kim CH; Lee JB; Koo BW
    Ann Surg Oncol; 2008 Jan; 15(1):281-5. PubMed ID: 17763975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
    Diel IJ; Cote RJ
    Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.
    Jang KS; Han HX; Paik SS; Brown PH; Kong G
    Cancer Lett; 2006 Dec; 244(2):203-10. PubMed ID: 16469432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological markers in human breast carcinoma.
    Walker RA
    J Pathol; 1982 Jun; 137(2):109-17. PubMed ID: 7045309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.